ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study

Nakamura, Kota; Zhu, Zhongxu; Roy, Souvick; Jun, Eunsung; Han, Haiyong; Munoz, Ruben M.; Nishiwada, Satoshi; Sharma, Geeta; Cridebring, Derek; Zenhausern, Frederic; Kim, Seungchan; Roe, Denise J.; Darabi, Sourat; Han, In-Woong; Evans, Douglas B.; Yamada, Suguru; Demeure, Michael J.; Becerra, Carlos; Celinski, Scott A.; Borazanci, Erkut; Tsai, Susan; Kodera, Yasuhiro; Park, Joon Oh; Bolton, John S.; Wang, Xin*; Kim, Song Cheol; Von Hoff, Daniel*; Goel, Ajay*chinese univ hong kong; new
Gastroenterology2022-11DOI: 10.1053/j.gastro.2022.06.090
23被引11阅读
引用收藏
分享

摘要

BACKGROUND & AIMS: Pancreatic ductal adenocarcinoma (PDAC) incidence is rising worldwide, and most patients present with an unresectable disease at initial diagnosis. Measurement of carbohydrate antigen 19-9 (CA19-9) levels lacks adequate sensitivity and specificity for early detection; hence, there is an unmet need to develop alternate molecular diagnostic biomarkers for PDAC. Emerging evidence suggests that tumor-derived exosomal cargo, particularly micro RNAs (miRNAs), offer an attractive platform for the development of cancer-specific biomarkers. Herein, genomewide profiling in blood specimens was performed to develop an exosome-based transcriptomic signature for noninvasive and early detection of PDAC. METHODS: Small RNA sequencing was undertaken in a cohort of 44 patients with an early-stage PDAC and 57 nondisease controls. Using machine-learning algorithms, a panel of cell-free (cf) and exosomal (exo) miRNAs were prioritized that discriminated patients with PDAC from control subjects. Subsequently, the performance of the biomarkers was trained and validated in independent cohorts (n = 191) using quantitative reverse transcription polymerase chain reaction (qRT-PCR) assays. RESULTS: The sequencing analysis initially identified a panel of 30 overexpressed miRNAs in PDAC. Subsequently using qRT-PCR assays, the panel was reduced to 13 markers (5 cf-and 8 exo-miRNAs), which successfully identified patients with all stages of PDAC (area under the curve [AUC] = 0.98 training cohort; AUC = 0.93 validation cohort); but more importantly, was equally robust for the identification of early-stage PDAC (stages I and II; AUC = 0.93). Furthermore, this transcriptomic signature successfully identified CA19-9 negative cases (<37 U/mL; AUC = 0.96), when analyzed in combination with CA19-9 levels, significantly improved the overall diagnostic accuracy (AUC = 0.99 vs AUC = 0.86 for CA19-9 alone). CONCLUSIONS: In this study, an exosome-based liquid biopsy signature for the noninvasive and robust detection of patients with PDAC was developed.

学科与关键词

关键词
miRNA SignatureExosomePancreatic CancerDiagnostic BiomarkerLiquid Biopsy
相关
加载中…
  • An exosomal miRNA-based liquid biopsy signature for the noninvasive early detection of pancreatic ductal adenocarcinoma
    Nakamura, Kota; Roy, Souvick; Zhu, Zhongxu; Jun, Eunsung; Han, Haiyong; Munoz, Ruben M.; Nishiwada, Satoshi; Sharma, Geeta; Cridebring, Derek; Zenhausern, Frederic; Kim, Seungchan; Roe, Denise; Darabi, Sourat; Han, In Woong; Evans, Douglas; Yamada, Suguru; Demure, Michael; Celinski, Scott A.; Borazanci, Erkut; Tsai, Susan; Bolton, John; Kodera, Yasuhiro; Park, Joon Oh; Kim, Song Cheol; Wang, Xin; Von Hoff, Daniel; Goel, AjayAnnual Meeting of the American-Association-for-Cancer-Research (AACR), New Orleans, LA, 2022-04-08 To 2022-04-13.
  • Salivary microRNAs Show Potential as a Noninvasive Biomarker for Detecting Resectable Pancreatic Cancer
    Xie Zijun; Yin Xiaoyu; Gong Bo; Nie Wenjing; Wu Bin; Zhang Xuchao; Huang Jian; Zhang Pingyou; Zhou Zhiwei; Li Zijun*CANCER PREVENTION RESEARCH, 2015, 8(2): 165-173.被引 7
  • Coupled liquid biopsy and bioinformatics for pancreatic cancer early detection and precision prognostication
    Hou, Jun; Li, XueTao; Xie, Ke-Ping*Molecular Cancer, 2021, 20(1): 34.被引 41
查看全部 →

发表信息

论文状态
公开发表
期刊
Gastroenterology
发表日期
2022-11
卷期
第 163 卷, 第 5 期
页码
1252-+
DOI
10.1053/j.gastro.2022.06.090
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
National Cancer Institute [U01 CA214254]; National Institutes of Health; Chinese University of Hong Kong [4937084]; Guangdong Basic and Applied Basic Research Foundation [2019B030302012]; Young Scientists Fund of the National Natural Science Foundation of China [81802384]

作者

  • N

    Nakamura, Kota (第一作者)

  • Z

    Zhu, Zhongxu

    chinese univ hong kong

查看全部 28 位作者收起作者
  • R

    Roy, Souvick

  • J

    Jun, Eunsung

  • H

    Han, Haiyong

  • M

    Munoz, Ruben M.

  • N

    Nishiwada, Satoshi

  • S

    Sharma, Geeta

  • C

    Cridebring, Derek

  • Z

    Zenhausern, Frederic

  • K

    Kim, Seungchan

  • R

    Roe, Denise J.

  • D

    Darabi, Sourat

  • H

    Han, In-Woong

  • E

    Evans, Douglas B.

  • Y

    Yamada, Suguru

  • D

    Demeure, Michael J.

  • B

    Becerra, Carlos

  • C

    Celinski, Scott A.

  • B

    Borazanci, Erkut

  • T

    Tsai, Susan

  • K

    Kodera, Yasuhiro

  • P

    Park, Joon Oh

  • B

    Bolton, John S.

    new

  • W

    Wang, Xin (通讯)

    chinese univ hong kong

  • K

    Kim, Song Cheol

  • V

    Von Hoff, Daniel (通讯)

  • G

    Goel, Ajay (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417